# pathway_0138: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0138.txt)

**Task:** `pathway`  
**Author key, unchanged:** **D** — Secondary metabolite biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR

[Multiple Choices]
A. L-fucose degradation. .
B. LPS O-antigen biosynthesis. .
C. terpenoid biosynthesis.
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.


**Missing item-specific fact**

> The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.


**Reason**

> Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported.


### Important caveats

- Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.
- The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.",
    "reason": "Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper."
  },
  "important_caveats": [
    "Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.",
    "The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.",
    "reason": "Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported."
  },
  "important_caveats": [
    "Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.",
    "The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.


**Missing item-specific fact**

> The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.


**Reason**

> While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "D"
]
```

> Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation.


### Important caveats

- The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.
- The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.
- The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.
- The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.",
    "reason": "While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational."
  },
  "important_caveats": [
    "The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.",
    "The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.",
    "The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "D"
    ],
    "reason": "Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational.",
    "evidence_ids": ["C5", "C6", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.",
    "missing_item_specific_fact": "The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.",
    "reason": "While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "D"],
    "reason": "Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation."
  },
  "important_caveats": [
    "The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.",
    "The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.",
    "The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.


**Reason**

> The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway.


### Important caveats

- The reviewer-only pathway annotation was not part of the original model input.
- The source's experimental evidence code supports the annotation but does not replace independent review of the cited study.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.",
    "reason": "The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments."
  },
  "important_caveats": [
    "The reviewer-only pathway annotation was not part of the original model input.",
    "The source's experimental evidence code supports the annotation but does not replace independent review of the cited study."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.",
    "reason": "The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway."
  },
  "important_caveats": [
    "The reviewer-only pathway annotation was not part of the original model input.",
    "The source's experimental evidence code supports the annotation but does not replace independent review of the cited study."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features.


### Important caveats

- The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.
- The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.
- Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.
- The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported."
  },
  "important_caveats": [
    "The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.",
    "The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.",
    "Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.",
    "The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported.",
    "evidence_ids": ["C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features."
  },
  "important_caveats": [
    "The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.",
    "The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.",
    "Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.",
    "The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A7T8F1L1",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "benchmark_sequence_length": 125,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 8,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2021-06-02",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "current_source_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "current_source_sequence_length": 125,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 6,
  "selected_historical_version": {
    "accession": "A0A7T8F1L1",
    "database": "Swiss-Prot",
    "entryVersion": 6,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "FRZH_CLASX",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "selected_historical_source_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "selected_historical_source_sequence_length": 125,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 6,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A7T8F1L1\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":8,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2021-06-02\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Hypocreaceae\",\"Cladobotryum\"],\"scientificName\":\"Cladobotryum sp\",\"taxonId\":2040732}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"FR901483 biosynthesis clusters protein H\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"5.5.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"Aldolase FrzH\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Zhang Z.\",\"Tamura Y.\",\"Tang M.\",\"Qiao T.\",\"Sato M.\",\"Otsu Y.\",\"Sasamura S.\",\"Taniguchi M.\",\"Watanabe K.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33372776\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.0c12352\"}],\"citationType\":\"journal article\",\"firstPage\":\"132\",\"id\":\"33372776\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"136\",\"publicationDate\":\"2021\",\"title\":\"Biosynthesis of the Immunosuppressant (-)-FR901483.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"11231\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   FRZH_CLASX              Reviewed;         125 AA.\nAC   A0A7T8F1L1;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   02-JUN-2021, sequence version 1.\nDT   28-JAN-2026, entry version 6.\nDE   RecName: Full=Aldolase FrzH {ECO:0000303|PubMed:33372776};\nDE            EC=5.5.1.- {ECO:0000269|PubMed:33372776};\nDE   AltName: Full=FR901483 biosynthesis clusters protein H {ECO:0000303|PubMed:33372776};\nGN   Name=FrzH {ECO:0000303|PubMed:33372776};\nOS   Cladobotryum sp.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.\nOX   NCBI_TaxID=2040732;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 6,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "source_locator": "lines 14-22",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND\nRP   PATHWAY.\nRC   STRAIN=11231;\nRX   PubMed=33372776; DOI=10.1021/jacs.0c12352;\nRA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,\nRA   Taniguchi M., Watanabe K., Tang Y.;\nRT   \"Biosynthesis of the Immunosuppressant (-)-FR901483.\";\nRL   J. Am. Chem. Soc. 143:132-136(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 6,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "source_locator": "lines 63-68",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000269|PubMed:33372776}.\nCC   ---------------------------------------------------------------------------\nCC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\nCC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\nCC   ---------------------------------------------------------------------------\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 6,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 138. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
